Head-to-head · WeighScore
Go Vida Plena vs Lttl
By GLP-1 ScorecardUpdated
Score comparison
Go Vida Plena has the higher recorded score — 68.2/100 to 63.5/100.
Go Vida Plena grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Go Vida Plena is a Spanish-first, Latino-focused medical weight-loss program offering GLP-1 therapy from $199/month, based in Utah.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Go Vida Plena | Lttl |
|---|---|---|
| WeighScore | 68.2/100 | 63.5/100 |
| Grade | C | C |
| Site position | #167 | #209 |
| Semaglutide | $199/mo (starting dose, compounded) | $99/mo monthly auto-refill; $89/mo equivalent billed $1,068 annually (confirm supply/renewal) |
| Tirzepatide | $269/mo (starting dose, compounded) | $149/mo monthly auto-refill; $139/mo equivalent billed $1,668 annually (confirm supply/renewal) |
| Coverage | Coverage not published | Provider claims 50 states + DC; treatment availability varies |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Yes | Yes |
Site position #167 · C
Strengths
- Spanish-first, fully bilingual GLP-1 program tailored to Latino food and lifestyle - a genuinely underserved niche
- Compounded semaglutide, tirzepatide, and oral semaglutide from $199/mo, with installment pay (Klarna, Afterpay, Affirm)
- Free initial consultation; medications shipped discreetly to your door after a medical evaluation
- Includes 24/7 support, 4 virtual visits a year, and ongoing nutrition coaching
- Physician-supervised program (Utah medical backing) with continuous follow-up
What to consider
- Utah-based, and the full list of states served is not published
- Only a '$199/mo starting' price is shown upfront; tirzepatide and oral-semaglutide pricing isn't published
- The compounding pharmacy is not named (a 'provider pharmacies' page exists but lists no name)
- Compounded GLP-1 medications are not FDA-approved - not brand Wegovy, Ozempic, Zepbound, or Mounjaro
- No LegitScript certification displayed
Site position #209 · C
Strengths
- Public ordinary monthly injection rates of $99 semaglutide and $149 tirzepatide, with longer-plan charges disclosed separately
- The plan selector identifies supply lengths, including four weeks for monthly auto-refill and 52 weeks annually
- Four possible dispensing pharmacies are named in the terms, without an individual assignment established
- Microdose injection and oral-tablet selector entries provide additional options to discuss with a clinician; availability and clinical suitability require confirmation
What to consider
- Monthly, quarterly and six-month supply labels do not align with calendar-month language; confirm actual refill and debit intervals
- Medical-rejection refund language conflicts with consultation-fee retention wording
- Terms use medical intake as a nonrefund boundary, while support uses pharmacy processing/shipping; refund deadlines also differ
- The assigned treating practice, prescriber and actual dispensing location remain unestablished
- Branded-service exceptions are described, but no available brand-specific prescription or price was established
- A 48-hour shipping headline differs from the policy estimate of two to five business days processing plus three to seven in transit
Featured provider
Lttl
Lttl scores 63.5/100 (C). Lttl publishes monthly and longer compounded-injection offers plus a low-dose and oral menu; compare the actual charge and supply interval because annual equivalents and four-week labels describe different commitments.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.